KRAS and Patent ductus arteriosus: The PDA cell line investigated here exhibits two of the most common driver mutations in PDA35,36, which are activating KRAS and p53 loss of function mutations24, both being reported to contribute to radioresistance of PDA via, for example, inactivation of the G1/S cell cycle checkpoint and dysregulation of apoptotic pathways23.